Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS) SHH

18.60

-0.04(-0.21%)

Updated at August 19 11:29AM

Currency In CNY

Valuation

Market Cap2.33B
Enterprise Value2.28B
P/E Ratio65.64
PEG Ratio1.01
Price/Sales Ratio4.17
Price/Book Ratio2.42
Enterprise/Revenue4.22
Enterprise/EBITDA39.34

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.06
Operating Margin0.07

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue827.4M
Revenue/Share5.05
Gross Profit175.95M
EBITDA126.08M
Net Income29.42M
Diluted EPS0.17

Balance Sheet

Total Cash245.57M
Total Cash/Share1.47
Total Debt286.52M
Total Debt/Equity0.22
Current Ratio2.96
Book Value Per Share7.83

Price History

52-Week Change69.4
52-Week High21.21
52-Week Low10.13
Moving Average 50 Days17.74
Moving Average 200 Days15.82

Statistics

Average Volume6.08M
Shares Outstanding189.03M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.33
Last Split Factor7:5
Last Split DateJune 08, 2020